Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells.
about
Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.New therapeutic targets for the antiphospholipid syndrome.Role of tissue factor in thrombosis in antiphospholipid antibody syndrome.Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factorsTreatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.Pathophysiological mechanisms in antiphospholipid syndromePregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies: a review of the literature.High antiphospholipid antibody levels are associated with statin use and may reflect chronic endothelial damage in non-autoimmune thrombosis: cross-sectional study.Platelets and the antiphospholipid syndrome.Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases.Tissue factor in the antiphospholipid syndrome.C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodiesA prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patientsAntiphospholipid syndrome treatment beyond anticoagulation: are we there yet?Potential use of statins in the treatment of antiphospholipid syndrome.Guidelines on the investigation and management of antiphospholipid syndrome.Statins and autoimmunity.Top 10 clinical research developments in antiphospholipid syndrome.Emerging Therapies in Antiphospholipid Syndrome.Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?Immunotherapeutic strategies in antiphospholipid syndrome.Pathogenesis and management of antiphospholipid syndrome.Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti-nonGal IgG binding to porcine aortic endothelial cells.More on: Fluvastatin inhibits upregulation of tissue factor expression by antiphospholipid antibodies on endothelial cells.More on: fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells.Diagnosis and management of the antiphospholipid syndrome.The chequered history of the antiphospholipid syndrome.Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodies.Novel therapies for the antiphospholipid syndrome.
P2860
Q33403225-E31AE606-B6A5-464D-B13C-B352700F068BQ34140319-84010257-985D-4460-A984-AAFD796E83EFQ34676688-93B9E8E6-DD7C-499A-830B-3C904FF3109CQ35067429-07BB6346-A27C-4098-A8D0-C596151342B9Q35621012-D9978CBC-7A03-41E4-ACF3-CA9551E064F9Q35849691-2C2E178A-3BC4-4C9D-BECE-5FF27565E8B9Q36671159-6306CDB4-EEC8-44A8-833F-2919D0F408BBQ36951078-55DA1952-AF7E-428E-9811-DAF0C4647529Q37141852-324BF244-C0DA-4F28-8221-9559E4DF2AD9Q37283013-66D9EA14-D521-4231-894A-C93719E3EF8AQ37283020-02570980-8BDF-4FFF-B52D-47CF348BC47AQ37283046-E21BE8A3-7D13-415E-9165-0ED539C45732Q37581827-249BC1E8-1388-454F-B7D2-589731ADDDD6Q37702168-B77FBC4C-B02C-4410-9A35-272D9BFB61D9Q37721617-B825029A-17A4-47B4-B63C-7609100F22B4Q37959316-7155B756-2A18-4C73-AC54-130D5938D586Q37982121-8B888E1A-79AF-465C-BCF9-EB6FD456A700Q38097749-FC5EA71B-E0DD-46FF-92F4-447AE8F463B2Q38135335-5CCAE9DB-41B2-45B6-88ED-2B21FCBE95CFQ38782057-A0384419-7A4A-46F8-8A13-BAD6033E6EBCQ38794847-9600E54D-8B81-4DC2-B11E-0591FCA1211EQ38826804-1C33DCC8-E27F-4766-A61C-B33F172F30CAQ39198671-F07DA466-D97B-49F4-8B17-376C57BA6A6DQ42395227-5143BFC3-7269-41E3-9290-6AF94D4ACE1BQ45302105-8ED4DDE0-040C-46D5-B6FC-4ACF79947C88Q46470748-C5A147FD-8C11-43F8-A4A6-7E50EFA0AEEAQ47982275-507DC431-9FE7-4ABF-BD26-53860CC33585Q48081474-F3D41DC6-85E3-4581-B7C0-DFBF677EA39BQ53190790-BEDADD59-02FB-4787-ACA6-30C91382351AQ53495449-902574CA-683C-4514-931E-7C18C64332F3
P2860
Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Fluvastatin inhibits up-regula ...... tibodies on endothelial cells.
@en
Fluvastatin inhibits up-regula ...... tibodies on endothelial cells.
@nl
type
label
Fluvastatin inhibits up-regula ...... tibodies on endothelial cells.
@en
Fluvastatin inhibits up-regula ...... tibodies on endothelial cells.
@nl
prefLabel
Fluvastatin inhibits up-regula ...... tibodies on endothelial cells.
@en
Fluvastatin inhibits up-regula ...... tibodies on endothelial cells.
@nl
P2093
P2860
P1476
Fluvastatin inhibits up-regula ...... tibodies on endothelial cells.
@en
P2093
Ferrara DE
Pierangeli SS
Swerlick R
Vega-Ostertag ME
P2860
P304
P356
10.1111/J.1538-7836.2004.00896.X
P577
2004-09-01T00:00:00Z